Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 12, 2021

BUY
$169.89 - $231.37 $0 - $0
0 New
0 $497,000
Q1 2021

Apr 21, 2021

SELL
$143.93 - $207.3 $405,882 - $584,586
-2,820 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$96.1 - $151.18 $271,002 - $426,327
2,820 New
2,820 $278,000
Q3 2020

Oct 21, 2020

SELL
$90.16 - $107.61 $254,251 - $303,460
-2,820 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$52.17 - $95.63 $147,119 - $269,676
2,820 New
2,820 $278,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Fulcrum Asset Management LLP Portfolio

Follow Fulcrum Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Asset Management LLP with notifications on news.